240 related articles for article (PubMed ID: 16940527)
1. CD80 and CD86 control antiviral CD8+ T-cell function and immune surveillance of murine gammaherpesvirus 68.
Fuse S; Obar JJ; Bellfy S; Leung EK; Zhang W; Usherwood EJ
J Virol; 2006 Sep; 80(18):9159-70. PubMed ID: 16940527
[TBL] [Abstract][Full Text] [Related]
2. Differential requirement for CD80 and CD80/CD86-dependent costimulation in the lung immune response to an influenza virus infection.
Lumsden JM; Roberts JM; Harris NL; Peach RJ; Ronchese F
J Immunol; 2000 Jan; 164(1):79-85. PubMed ID: 10604996
[TBL] [Abstract][Full Text] [Related]
3. Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway.
Shanafelt MC; Kang I; Barthold SW; Bockenstedt LK
Infect Immun; 1998 Jan; 66(1):266-71. PubMed ID: 9423867
[TBL] [Abstract][Full Text] [Related]
4. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.
van Wijk F; Nierkens S; de Jong W; Wehrens EJ; Boon L; van Kooten P; Knippels LM; Pieters R
J Immunol; 2007 Jun; 178(11):6894-900. PubMed ID: 17513738
[TBL] [Abstract][Full Text] [Related]
5. Differential requirement for CD28 and CD80/86 pathways of costimulation in the long-term control of murine gammaherpesvirus-68.
Lyon AB; Sarawar SR
Virology; 2006 Dec 5-20; 356(1-2):50-6. PubMed ID: 16934307
[TBL] [Abstract][Full Text] [Related]
6. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
7. Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response.
Fuse S; Zhang W; Usherwood EJ
J Immunol; 2008 Jan; 180(2):1148-57. PubMed ID: 18178855
[TBL] [Abstract][Full Text] [Related]
8. Differential requirement for CD28/CTLA-4-CD80/CD86 interactions in drug-induced type 1 and type 2 immune responses to trinitrophenyl-ovalbumin.
Nierkens S; Aalbers M; Bol M; Bleumink R; van Kooten P; Boon L; Pieters R
J Immunol; 2005 Sep; 175(6):3707-14. PubMed ID: 16148116
[TBL] [Abstract][Full Text] [Related]
9. B7+ T cells in myeloma: an acquired marker of prior chronic antigen presentation.
Brown R; Murray A; Pope B; Sze D; Gibson J; Ho PJ; Joshua D
Leuk Lymphoma; 2004 Feb; 45(2):363-71. PubMed ID: 15101725
[TBL] [Abstract][Full Text] [Related]
10. Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions.
Greene JL; Leytze GM; Emswiler J; Peach R; Bajorath J; Cosand W; Linsley PS
J Biol Chem; 1996 Oct; 271(43):26762-71. PubMed ID: 8900156
[TBL] [Abstract][Full Text] [Related]
11. Expression and contribution of B7-1 (CD80) and B7-2 (CD86) in the early immune response to Leishmania major infection.
Elloso MM; Scott P
J Immunol; 1999 Jun; 162(11):6708-15. PubMed ID: 10352289
[TBL] [Abstract][Full Text] [Related]
12. Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86.
Manzotti CN; Liu MK; Burke F; Dussably L; Zheng Y; Sansom DM
Eur J Immunol; 2006 Jun; 36(6):1413-22. PubMed ID: 16708397
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of CD80, CD86 and CD70 on T cells from HIV-infected individuals upon activation in vitro: regulation by CD4+ T cells.
Wolthers KC; Otto SA; Lens SM; Kolbach DN; van Lier RA; Miedema F; Meyaard L
Eur J Immunol; 1996 Aug; 26(8):1700-6. PubMed ID: 8765009
[TBL] [Abstract][Full Text] [Related]
14. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
Mukherjee S; Ahmed A; Nandi D
J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
[TBL] [Abstract][Full Text] [Related]
15. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
[TBL] [Abstract][Full Text] [Related]
16. Effect of CD80 and CD86 on T cell cytokine production.
Petro TM; Chen SS; Panther RB
Immunol Invest; 1995 Nov; 24(6):965-76. PubMed ID: 8575841
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
[TBL] [Abstract][Full Text] [Related]
18. Nucleic acid vaccine-induced immune responses require CD28 costimulation and are regulated by CTLA4.
Horspool JH; Perrin PJ; Woodcock JB; Cox JH; King CL; June CH; Harlan DM; St Louis DC; Lee KP
J Immunol; 1998 Mar; 160(6):2706-14. PubMed ID: 9510170
[TBL] [Abstract][Full Text] [Related]
19. Interactions of CD80 and CD86 with CD28 and CTLA4.
Ellis JH; Burden MN; Vinogradov DV; Linge C; Crowe JS
J Immunol; 1996 Apr; 156(8):2700-9. PubMed ID: 8609386
[TBL] [Abstract][Full Text] [Related]
20. Role of CD28/CD80-86 and CD40/CD154 costimulatory interactions in host defense to primary herpes simplex virus infection.
Edelmann KH; Wilson CB
J Virol; 2001 Jan; 75(2):612-21. PubMed ID: 11134274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
